Last reviewed · How we verify
NCT06233487
Reliability of Ultrasound Metrics Used in Hip Dysplasia Diagnostics - a Prospective Study
NA trial testing Repeat hip ultrasound measurements in Developmental Dysplasia of the Hip in 74 participants. Completed in 7 February 2026.
7 February 2026
Quick facts
| Lead sponsor | Aarhus University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 74 |
| Start date | 27 February 2024 |
| Primary completion | 7 February 2026 |
| Estimated completion | 7 February 2026 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Repeat hip ultrasound measurements
Conditions studied
- Developmental Dysplasia of the Hip — all drugs for Developmental Dysplasia of the Hip →
Sponsor
Aarhus University Hospital
Who can join
Adults 0 Months to 6 Months, any sex, with Developmental Dysplasia of the Hip. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Several measurements are used to evaluate hip dysplasia in hip ultrasound of children. Despite having being used since the 1980s, reliability studies have failed to find acceptable reliaiblity values for the gold standard ultrasound methods. This study will evaluate three ultrasound measurement methodologies in a high quality controlled setting, to investigate the best achieveable reliability and agreement of the investigated measurements used in hip dysplasia diagnostics.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06233487
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Developmental Dysplasia of the Hip
Currently open trials in the same condition.
- NCT06512506 — Prospective Cohort Study of Arthroscopic Treatment of Hip Dysplasia · recruiting
- NCT04101903 — Evaluation of Aid to Diagnosis for Congenital Dysplasia of the Hip in General Practice · NA · active not recruiting
- NCT05186168 — Corin MiniHip and Trinity Cup Clinical Surveillance Study · active not recruiting
Other Aarhus University Hospital trials
Trials by the same sponsor.
- NCT07432802 — Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer · NA · not yet recruiting
- NCT07499336 — UNDERSTANDING THE T-CELL AND B-CELL RECEPTOR REPERTOIRE IN CHILDREN AND YOUNG ADULTS WITH ANTI-DRUG ANTIBODIES AGAINST P · not yet recruiting
- NCT07454486 — TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cance · not yet recruiting
- NCT07284069 — Senicapoc and Perampanel for Newly Diagnosed Glioblastoma · EARLY_PHASE1 · recruiting
- NCT07426250 — Clinical Utility of ctDNA in the Treatment of Oligometastatic Disease · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06233487 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aarhus University Hospital
- Last refreshed: 10 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06233487.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing